Related references
Note: Only part of the references are listed.Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study
Jordana Kron et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2023)
Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children
Edoardo Conte et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)
Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy
Daniel Harding et al.
JOURNAL OF INTERNAL MEDICINE (2023)
SARS-COV-2 AND MRNA VACCINE-ASSOCIATED RECURRENT PERICARDITIS TREATED WITH RILONACEPT
John Clark Shell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)
Colchicine for cardiovascular prevention: the dawn of a new era has finally come
Aldo Bonaventura et al.
EUROPEAN HEART JOURNAL (2023)
Immune checkpoint inhibitor-associated myocarditis: from pathophysiology to rechallenge of therapy - a narrative review
Andrea Tedeschi et al.
FUTURE CARDIOLOGY (2023)
Treatment of Idiopathic Recurrent Pericarditis With Goflikicept Phase II/III Study Results
Valentina Yu. Myachikova et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)
Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis
Mathieu Kerneis et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2023)
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials
Antonio Abbate et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis
Enrico Ammirati et al.
CIRCULATION (2022)
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis
Ryan Ruiyang Ling et al.
LANCET RESPIRATORY MEDICINE (2022)
COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation
Muhammad Furqan et al.
CURRENT CARDIOLOGY REPORTS (2022)
Myocarditis
Cristina Basso
NEW ENGLAND JOURNAL OF MEDICINE (2022)
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
[Anonymous]
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Systematic Review/Meta-analysis Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Michelle Samuel et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience
Nisha A. Gilotra et al.
JOURNAL OF CARDIAC FAILURE (2021)
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Carsten Tschoepe et al.
NATURE REVIEWS CARDIOLOGY (2021)
Pericarditis Recurrence After Initial Uncomplicated Clinical Course
Marco Giuseppe Del Buono et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis
Alberto Aimo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
Allan L. Klein et al.
HEART (2021)
Anti-interleukin 1 agents for the treatment of recurrent pericarditis
M Imazio et al.
EUROPEAN HEART JOURNAL (2021)
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
Allan L. Klein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinical outcomes of patients with isolated cardiac sarcoidosis confirmed by clinical diagnostic criteria
Yoichi Takaya et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients
Antonio Abbate et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)
Jordana Kron et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Arrhythmias in Cardiac Sarcoidosis Bench to Bedside A Case-Based Review
Lynda E. Rosenfeld et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2021)
Immune checkpoint inhibitor-associated myocarditis: manifestations arms mechanisms
Javid Moslehi et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
An update on the pathophysiology of acute and recurrent pericarditis
Aldo Bonaventura et al.
PANMINERVA MEDICA (2021)
Macrophage depletion in stellate ganglia alleviates cardiac sympathetic overactivation and ventricular arrhythmogenesis by attenuating neuroinflammation in heart failure
Dongze Zhang et al.
BASIC RESEARCH IN CARDIOLOGY (2021)
Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors
Saberio Lo Presti et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
Alessandra Vecchie et al.
CURRENT CARDIOLOGY REPORTS (2021)
Colchicine and the heart
Massimo Imazio et al.
EUROPEAN HEART JOURNAL (2021)
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
Kaspar Broch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Targeting inflammation in atherosclerosis - from experimental insights to the clinic
Oliver Soehnlein et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
Peter Libby
CELLS (2021)
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report
Ammar A. Hasnie et al.
BMC CARDIOVASCULAR DISORDERS (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients
Benjamin J. R. Buckley et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Myocarditis and Pericarditis After Vaccination for COVID-19
George A. Diaz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
Marco Giuseppe Del Buono et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review
Siavosh Fazelpour et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
The Role of NLRP3 Inflammasome in Pericarditis
Adolfo G. Mauro et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure
George F. Wohlford et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)
Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)
David Birnie et al.
AMERICAN HEART JOURNAL (2020)
IL-1-dependent electrophysiological changes and cardiac neural remodeling in a mouse model of Kawasaki disease vasculitis
M. Abe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate et al.
CIRCULATION RESEARCH (2020)
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction
Antonio Abbate et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
Dave L. Dixon et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis
George F. Wohlford et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Clinical Presentation and Outcomes of Acute Pericarditis in a Large Urban Hospital in the United States of America
Alessandra Vecchie et al.
CHEST (2020)
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis
Adelina Yafasova et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Weathering the Cytokine Storm in COVID-19: Therapeutic Implications
Giulia Iannaccone et al.
CARDIORENAL MEDICINE (2020)
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiovascular implications of COVID-19 versus influenza infection: a review
Muhammad Shahzeb Khan et al.
BMC MEDICINE (2020)
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy An Expert Consensus Document
Enrico Ammirati et al.
CIRCULATION-HEART FAILURE (2020)
Blocking the IL-1 signalling pathway prevents chronic viral myocarditis and cardiac remodeling
Lisa Kraft et al.
BASIC RESEARCH IN CARDIOLOGY (2019)
Inflammasome Formation in Granulomas in Cardiac Sarcoidosis
Jordana Kron et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)
Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis
David G. Rosenthal et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiac Sarcoidosis
Pranav Mankad et al.
CURRENT CARDIOLOGY REPORTS (2019)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Brendan M. Everett et al.
CIRCULATION (2019)
Reassessing the Mechanisms of Acute Coronary Syndromes The Vulnerable Plaque and Superficial Erosion
Peter Libby et al.
CIRCULATION RESEARCH (2019)
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Chronic inflammation in the etiology of disease across the life span
David Furman et al.
NATURE MEDICINE (2019)
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein
Cory R. Trankle et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe et al.
CIRCULATION RESEARCH (2018)
Interleukin-1 beta has atheroprotective effects in advanced atherosclerotic lesions of mice
Delphine Gomez et al.
NATURE MEDICINE (2018)
Myocarditis: An Interleukin-1-Mediated Disease?
Giacomo De Luca et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2018)
Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction
Nicole M. De Jesus et al.
HEART RHYTHM (2017)
Eosinophilic Myocarditis Characteristics, Treatment, and Outcomes
Michela Brambatti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy
Aneta Aleksova et al.
ONCOTARGET (2017)
Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
Giulio Cavalli et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2017)
NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis
Carsten Tschoepe et al.
CIRCULATION-HEART FAILURE (2017)
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)
Benjamin W. Van Tassell et al.
CLINICAL CARDIOLOGY (2017)
Treating Life-Threatening Myocarditis by Blocking Interleukin-1
Giulio Cavalli et al.
CRITICAL CARE MEDICINE (2016)
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-STelevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial+
Ola Kleveland et al.
EUROPEAN HEART JOURNAL (2016)
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence The AIRTRIP Randomized Clinical Trial
Antonio Brucato et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study
Benjamin W. Van Tassell et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
The Inflammasome in Myocardial Injury and Cardiac Remodeling
Stefano Toldo et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
Atherosclerosis exacerbates arrhythmia following myocardial infarction: Role of myocardial inflammation
Nicole M. De Jesus et al.
HEART RHYTHM (2015)
Formation of the inflammasome during cardiac allograft rejection
Keyur B. Shah et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
The Importance of NLRP3 Inflammasome in Heart Failure
Brittany Butts et al.
JOURNAL OF CARDIAC FAILURE (2015)
Pathophysiology and clinical management of cardiac sarcoidosis
Nabeel Hamzeh et al.
NATURE REVIEWS CARDIOLOGY (2015)
Anti-inflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution?
Antonio Abbate et al.
EUROPEAN HEART JOURNAL (2015)
The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
Allison C. Morton et al.
EUROPEAN HEART JOURNAL (2015)
Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)
Benjamin Wallace Van Tassell et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
Yan Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis
Konstantinos Savvatis et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)
Vincent M. van Deursen et al.
CIRCULATION (2014)
Formation of the inflammasome in acute myocarditis
Stefano Toldo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure A Prospective, Randomized Study
Spyridon Deftereos et al.
JACC-HEART FAILURE (2014)
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth. University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression
Riina Kandolin et al.
CIRCULATION-HEART FAILURE (2013)
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management
Alida L. P. Caforio et al.
HEART FAILURE REVIEWS (2013)
Interleukin-1β induces a reversible cardiomyopathy in the mouse
Benjamin W. Van Tassell et al.
INFLAMMATION RESEARCH (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
Matthew R. Alexander et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
Benjamin W. Van Tassell et al.
PLOS ONE (2012)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy
Przemyslaw Blyszczuk et al.
CIRCULATION RESEARCH (2009)
BNP-Guided vs Symptom-Guided Heart Failure Therapy The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) Randomized Trial
Matthias Pfisterer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
Antonio Abbate et al.
CIRCULATION (2008)
Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy
Elena Westphal et al.
MOLECULAR MEDICINE (2008)
Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice
F Merhi-Soussi et al.
CARDIOVASCULAR RESEARCH (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size
CM Devlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)